View the Impact of Your Research in Synapse

Posted on by

Whether for a grant proposal, annual review, CV, or just plain curiosity, authors often seek to measure the impact of their research. Synapse, our database of MSK authors and their publications, is a quick and reliable source for two common research metrics: citation counts (Dimensions), and online attention (Altmetrics).  From your author profile page, you can select any of your publications and quickly view the current research impact (if available) of your work via these two products from Digital Science.

CSF1/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment. Molecular Cancer Therapeutics. 2021. DOI: 10.1158/1535-7163.Mct-20-0591

Taking a look at this example record, you can see that the article has been cited 45 times, according to Dimensions. Clicking on the citation badge links out to the Dimensions page, allowing you to directly see the works that have cited your article.  The article was also mentioned by 5 news outlets, 1 tweet, and has 35 readers in Mendeley.

Altmetric detail page

If you click on the colored donut you will be taken to the Altmetric page where you can view additional information regarding the paper’s online attention, such as direct links to news stories and tweets. 

They also provide additional details comparing the article to other tracked outputs of a similar age and/or source journals. Our example is in the top 5% of all research outputs tracked by Altmetric, and the top 97th percentile of all outputs from the same source journal and age. 

For assistance on research metrics or questions about Synapse, contact us. 

Breast and Uterine Cancer in the News

Posted on by

MSK experts in breast and gynecological cancers were recently featured in the media.

Photos of Dr. Maxine Jochelson and Dr. Ginger Gardner.
Dr. Maxine Jochelson (left, photo by Richard DeWitt) and Dr. Ginger Gardner (right, photo by Karsten Moran).

Verywell Health spoke to Dr. Maxine Jochelson for an article on breast cancer screening best practices. A recent study used epidemiological data broken down by race and ethnicity to conclude that different populations should start screening for breast cancer at varying ages. Dr. Jochelson said that the potential for false positives is not a reason not to get screened, and that women should work with their healthcare providers to determine the screening schedule that is right for them.

The New York Times featured Dr. Ginger Gardner in an article about uterine cancer. While US uterine cancer rates remain low they are rising, especially among Black and Hispanic populations. Dr. Gardner said that family history and health conditions like diabetes and hypertension increase a person’s risk for the disease. Patients should pay attention to symptoms, including unexpected vaginal bleeding or spotting, and get examined if symptoms are present.

Learn more about MSK’s Female Sexual Medicine & Women’s Health Program.

“Society of Gynecologic Oncology” 2023 Podcast Recap

Posted on by

In the ‘Oncology On-The-Go’ Podcast posted on April 24th, 2023, Dr. Ritu Salani and Dr. Dana Chase discussed results presented at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting with CancerNetwork®.

Dr. Salani and Dr. Chase are providers at the University of California Los Angeles (UCLA). They spoke about key findings and possibilities for improving patients’ quality of life. They reviewed the results from those three trials: